Autonomix Medical (AMIX) Common Equity (2022 - 2025)

Autonomix Medical (AMIX) has 4 years of Common Equity data on file, last reported at $8.6 million in Q4 2025.

• Common Equity for Q4 2025 came in at $8.6 million, down 11.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.6 million (down 11.81% YoY), and the FY2025 annual result was $8.1 million, up 6.17% from the prior year.
• Common Equity rose to $8.6 million in Q4 2025 per AMIX's latest filing, from $6.4 million in the prior quarter.
• Over five years, Common Equity peaked at $9.7 million in Q4 2024 and troughed at -$5.6 million in Q4 2023.
• A 4-year average of $3.9 million and a median of $5.3 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2024: Common Equity tumbled 993.77% in 2023, then surged 1084.47% in 2024.
• A 4-year view of Common Equity shows it stood at $626000.0 in 2022, then plunged by 993.77% to -$5.6 million in 2023, then jumped by 273.49% to $9.7 million in 2024, then dropped by 11.81% to $8.6 million in 2025.
• Business Quant data shows AMIX's Common Equity at $8.6 million in Q4 2025, $6.4 million in Q3 2025, and $7.0 million in Q2 2025.